查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1901565

生物指標市場：依產品、方法、最終用途、國家及地區分類－全球產業分析、市場規模、市場佔有率及2025-2032年預測

Biological Indicators Market, By Product, By Method, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年生物指標市場規模價值為 5.3289 億美元，從 2025 年到 2032 年將以 8.5% 的複合年成長率成長。

生物指示劑是一種利用細菌孢子等高耐受性微生物直接檢測滅菌處理效果的測試工具。它透過使指示孢子失活來確保蒸氣或氣體等滅菌處理已徹底殺滅所有可能有害的病菌。生物指示劑是檢測滅菌效果的最佳方法，因為它能直接顯示滅菌方法是否殺滅了目標微生物，而不僅是顯示滅菌循環的各項參數均已達到要求。醫療保健和製藥業對滅菌驗證的監管要求日益嚴格，以及全球範圍內對感染控制和安全標準的日益重視，推動了生物指標市場的成長。然而，與化學指示劑相比，生物指標的高昂成本是限制其產業發展的主要挑戰。

生物指示劑市場－市場動態

製藥和生物製藥製造業的成長推動了市場成長。

由於越來越多的製藥和生物製藥企業需要在生產過程中保持產品的清潔無污染，生物指標市場正在蓬勃發展。隨著這些領域的成長，無菌藥物、疫苗和生物製劑的生產需要對滅菌方法進行嚴格的測試，以確保產品的安全性和有效性。生物指示劑在確保滅菌技術能有效殺死細菌方面尤其重要。這對於遵守相關指南和保障病人安全至關重要。隨著更先進的生物製劑和個人化療法的出現，對可靠的滅菌監測的需求不斷成長，從而推動了市場擴張。此外，製藥和生物製藥生產行業日益嚴格的法律法規和更高的品質標準表明，先進的生物指標仍將發揮重要作用。這將使該細分市場保持旺盛的需求。

生物指示劑市場區隔分析：

全球市場按產品、方法、最終用途和地區進行細分。

根據產品類型，自封式（小瓶/安瓿）在基準年佔據最大的市場佔有率。孢子載體和培養基合而為一的設計使其易於使用、安全便捷，從而促進了其市場擴張。這種設計使製藥企業和醫療機構能夠輕鬆確保其滅菌流程的有效性，從而提高其可靠性和效率。預計未來幾年，自封式滅菌產品產業將以最快的速度成長，因為它能夠提供精確的結果並簡化操作。這是因為人們對快速簡便的滅菌監測方法的需求日益成長。

根據滅菌方法，蒸氣滅菌在預測期內將佔據最大的收入佔有率。其成長的原因在於蒸氣滅菌有效、安全且成本低廉，能夠徹底清除抗藥性細菌。它仍然是醫院清潔手術器械、實驗室清潔可重複使用的玻璃器皿以及製藥業清潔生產設備和培養基的最常用方法。蒸氣滅菌高壓滅菌器廣泛應用於手術室及中央消毒供應室（CSSD），以保障病人安全。此外，蒸氣滅菌也是藥品生產過程中的常見步驟，確保生產過程清潔並符合嚴格的規範。由於蒸氣滅菌用途廣泛且有完善的規範，因此一直是首選的滅菌方法。

生物指示劑市場—地理洞察

生物指標市場呈現出顯著的地域差異，這主要受政府嚴格監管和製藥業蓬勃發展的推動。亞太地區是該市場成長最快的地區，其成長主要歸功於製藥業的快速擴張和醫院感染率的上升，尤其是中國、日本、韓國和印度等國家。該地區的領先製造商正積極推出新產品以滿足不斷成長的需求。北美地區繼續主導市場成長，這得益於其成熟的製藥和生物製藥行業，以及該地區眾多知名企業的存在。拉丁美洲、中東和非洲等新興地區也在醫療基礎建設的完善和政府支持的加強下，逐漸擴大市場佔有率。

美國生物指示劑市場—國家概況

在北美，美國市場在預測期內將以驚人的速度成長。美國市場的成長歸因於許多因素，例如醫院感染（HAI）的增加以及輝瑞、雅培等眾多知名製藥公司的存在。例如，美國疾病管制與預防中心（CDC）的報告指出，到2023年，美國醫院重症監護室（ICU）患者中約有19.5%至少感染過一種醫院感染，這凸顯了消毒監測的關鍵作用。

此外，包括數位化監控系統和自動化滅菌操作在內的技術進步，正使生物指示劑更加可靠有效。同時，對感染控制和病人安全的日益重視，也促使醫療機構採用更先進的滅菌驗證技術，進一步推動了市場的發展。

目錄

第1章：生物指示劑市場概覽

  • 研究範圍
  • 市場估算年份

第2章：執行概要

  • 市集
  • 競爭洞察

第3章：生物指標主要市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場未來趨勢

第4章：生物指示劑產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 規範架構分析

第5章：生物指標市場：地緣政治緊張局勢升級的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：生物指示劑市場概況

  • 生物指示劑市場佔有率分析，2024年
  • 主要製造商細分數據
    • 知名球員分析
    • 新興參與者分析

第7章：生物指示劑市場：依產品分類

  • 概述
    • 細分市場佔有率分析：依產品分類
    • 自封式（小瓶/安瓿）
    • 條狀物
    • 卡片/快速讀取BIS
    • 其他

第8章：生物指標市場：依方法分類

  • 概述
    • 細分市場佔有率分析：依方法
    • 蒸氣滅菌
    • 環氧乙烷滅菌
    • 過氧化氫滅菌
    • 輻照滅菌（伽瑪射線、電子束）
    • 乾熱滅菌

第9章：生物指示劑市場：依最終用途分類

  • 概述
    • 醫院和診所（CSSD/感染控制部門）
    • 門診手術中心（ASC）和牙科診所
    • 生物製藥和生物技術公司
    • 醫療器材製造商
    • 合約滅菌服務提供者
    • 研究與學術機構
    • 其他

第10章：生物指標市場：依地域分類

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • その他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • その他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • その他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • その他

第11章：主要供應商分析：生物指標產業

  • 競爭格局分析
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Mesa Labs, Inc.
    • LISTER BioMedical
    • STERIS plc.
    • Solventum
    • Getinge
    • 3M
    • Terragene SA
    • Propper Manufacturing Co., Inc.
    • Tuttnauer
    • Ecolab Inc.
    • HWAndersen Products Ltd.
    • MATACHANA GROUP
    • Liofilchem Srl
    • Steelco SpA
    • Zhejiang Tailin Bioengineering Co., Ltd.

第12章：全面展望

簡介目錄
Product Code: ANV5899

The Biological Indicators Market size was valued at US$ 532.89 Million in 2024, expanding at a CAGR of 8.5% from 2025 to 2032.

A biological indicator is a test tool that uses very resistant microorganisms, like bacterial spores, to directly check how well a sterilizing treatment works. It is used to make sure that a sterilizing treatment, like steam or gas, has killed all germs that could be harmful by making the indicator spores inactive. Biological indicators are the best way to check if sterilization worked since they show that the approach killed the right microbes instead of just showing that the parameters for a sterilization cycle were met. The market growth is driven by the increasing regulatory requirements for sterilization validation in healthcare and pharmaceutical industries, as well as rising awareness about infection control and safety standards worldwide. However, the high cost compared to chemical indicators poses a major challenge to the industry growth.

Biological Indicators Market- Market Dynamics

Growth of the pharmaceutical & biopharmaceutical manufacturing drives the market growth

The biological indicators market is rising because more pharmaceutical and biopharmaceutical businesses need to keep their goods clean and free of contamination while they are being made. As these fields grow, making sterile drugs, vaccines, and biologics requires strict testing of sterilization methods to make sure the products are safe and work. Biological indicators are particularly useful for making sure that sterilization techniques get rid of germs. This is vital to obey the guidelines and keep patients safe. The demand for reliable sterilization monitoring has grown as more advanced biologic medications and personalized therapy have become available. This has led to market expansion. Also, stiffer laws and higher quality standards in the pharmaceutical and biopharmaceutical production industries indicate that advanced biological markers will still be needed. This will maintain this market segment in high demand.

Biological Indicators Market- Segmentation Analysis:

The worldwide market is segmented on the basis of Product, Method, End Use and Region.

Based on the product, the self-contained (vials/ampoules) holds the largest market share in the base year. The fact that the spore carrier and growing media are combined into one unit makes it easy to use, safe, and convenient, which has led to its expansion. This design makes it easy for pharmaceutical businesses and healthcare facilities to make sure that their sterilizing processes are working. This makes them more reliable and efficient. The self-contained industry is predicted to grow the fastest over the next few years because it can give precise results and make operations easier. This is because there is a rising need for quick and easy ways to keep an eye on sterilization.

Based on the method, the steam sterilization segment holds the largest revenue share over the forecast period. This growth is because it works, is safe, and is cheap to get rid of bacteria that are resistant. It is still the most frequent approach to clean surgical tools in hospitals, glassware that may be used again in labs, and manufacturing equipment and culture medium in the pharmaceutical business. Steam sterilization autoclaves are widely used in operating rooms and central sterile supply departments (CSSDs) to keep patients safe. Also, steam sterilization is a common part of making drugs to make sure that the processes are clean and follow stringent guidelines. Since it may be used in so many various ways and is backed by rules, steam sterilization has been the most preferred approach.

Biological Indicators Market- Geographical Insights

The Biological Indicators market shows significant geographical variation, driven by the strict rules imposed by the government and growing pharmaceutical sector. The Asia Pacific experiencing a fastest growth in the market. Growth is due to rapid expansion in pharmaceutical sector and increasing HAI, especially in countries like China, Japan, South Korea, and India. Leading manufacturers in this region actively launch new products to cater to this surging demand. North America continues to dominate the market growth. It is propelled by the established pharmaceutical and biopharmaceutical sector. In addition, the presence of established player in the area. Emerging regions such as Latin America, the Middle East, and Africa are gradually growing their footprint, fueled by expansion of healthcare infrastructure and the increasing government support.

US Biological Indicators Market- Country Insights

In North America, the US market is growing at a staggering rate over the projected period. The growth of the market in the US is attributed to the number of factors such as increasing HAI and the presence of established pharmaceutical sector such as Pfizer, Abbott and many others. For instance, a CDC report highlighted that in 2023, approximately 19.5% of ICU patients across U.S. hospitals had at least one HAI, emphasizing the critical role of sterilization monitoring.

Also, technological improvements, including adding digital monitoring systems and automating sterilizing operations, are making biological indicators more reliable and effective. Also, the increased focus on infection control and patient safety is pushing healthcare facilities to use more modern sterilization validation technologies, which is helping the market develop even more.

Biological Indicators Market- Competitive Landscape:

The biological indicators market will have both big, well-known companies and smaller, more specialized ones in 2024. Some of the best companies that will be competing are 3M, Getinge Group, and Steris. These firms set the norm by creating biological markers that are high-tech, easy to use, and reliable. These indicators usually come with quick-readout and automatic solutions to help with productivity and obeying the laws. The market is getting more competitive because more and more individuals require cheap ways to check for sterilization. This is because of strict laws and the surge in infections that happen in hospitals and other healthcare settings (HAIs). Companies in the market want to take advantage of opportunities for growth, therefore one of their main strategies is to go into new areas, especially in countries that are booming, like Asia-Pacific. North America and Europe's economies are still the strongest because they have well-developed healthcare systems and tight rules. But investments in the health care and drug industries ensure that new markets have a lot of room to grow. There are restrictions on the market, such as the high costs of advanced indicators and the fact that there are other ways to keep an eye on sterilization. But new ideas and strong partnerships are still what keeps the sector developing and businesses competitive.

Recent Developments:

In April 2024, 3M finalized the spin-off of its healthcare division, officially launching Solventum Corporation as an independent entity. The company is now listed on the New York Stock Exchange under the ticker symbol SOLV.

In June 2025, Solventum introduced its Attest Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack. This ready-to-use test combines two previously FDA-cleared indicators, a biological indicator (BI) for verifying microbial inactivation and a chemical indicator (CI) for confirming proper sterilizer function, into a single-use pack with a transparent container for easy and reliable sterilization validation.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOLOGICAL INDICATORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Mesa Labs, Inc.
  • LISTER BioMedical
  • STERIS plc.
  • Solventum
  • Getinge
  • 3M
  • Terragene S.A.
  • Propper Manufacturing Co., Inc.
  • Tuttnauer
  • Ecolab Inc.
  • H.W.Andersen Products Ltd.
  • MATACHANA GROUP
  • Liofilchem S.r.l.
  • Steelco S.p.A
  • Zhejiang Tailin Bioengineering Co., Ltd.

GLOBAL BIOLOGICAL INDICATORS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Self-Contained (Vials/Ampoules)
  • Strips
  • Cards / Rapid Readout Bis
  • Others

GLOBAL BIOLOGICAL INDICATORS MARKET, BY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Steam Sterilization
  • Ethylene Oxide Sterilization
  • Hydrogen Peroxide Sterilization
  • Irradiation Sterilization (Gamma, E-beam)
  • Dry Heat Sterilization

GLOBAL BIOLOGICAL INDICATORS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics (CSSD / Infection Control Units)
  • Ambulatory Surgery Centers (ASCs) & Dental Clinics
  • Biopharma & Biotech Companies
  • Medical Device Manufacturers
  • Contract Sterilization Service Providers
  • Research & Academic Institutes
  • Others

GLOBAL BIOLOGICAL INDICATORS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Biological Indicators Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biological Indicators Market Snippet by Product
    • 2.1.2. Biological Indicators Market Snippet by Method
    • 2.1.3. Biological Indicators Market Snippet by End Use
    • 2.1.4. Biological Indicators Market Snippet by Country
    • 2.1.5. Biological Indicators Market Snippet by Region
  • 2.2. Competitive Insights

3. Biological Indicators Key Market Trends

  • 3.1. Biological Indicators Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biological Indicators Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biological Indicators Market Opportunities
  • 3.4. Biological Indicators Market Future Trends

4. Biological Indicators Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biological Indicators Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Biological Indicators Market Landscape

  • 6.1. Biological Indicators Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biological Indicators Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024&2032 (%)
    • 7.1.2. Self-Contained (Vials/Ampoules)
    • 7.1.3. Strips
    • 7.1.4. Cards / Rapid Readout Bis
    • 7.1.5. Others

8. Biological Indicators Market - By Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Method, 2024&2032 (%)
    • 8.1.2. Steam Sterilization
    • 8.1.3. Ethylene Oxide Sterilization
    • 8.1.4. Hydrogen Peroxide Sterilization
    • 8.1.5. Irradiation Sterilization (Gamma, E-beam)
    • 8.1.6. Dry Heat Sterilization

9. Biological Indicators Market - By End Use

  • 9.1. Overview
    • 9.1.1. Hospitals & Clinics (CSSD / Infection Control Units)
    • 9.1.2. Ambulatory Surgery Centers (ASCs) & Dental Clinics
    • 9.1.3. Biopharma & Biotech Companies
    • 9.1.4. Medical Device Manufacturers
    • 9.1.5. Contract Sterilization Service Providers
    • 9.1.6. Research & Academic Institutes
    • 9.1.7. Others

10. Biological Indicators Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Biological Indicators Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Biological Indicators Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Biological IndicatorsKey Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Biological Indicators Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Biological IndicatorsKey Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Biological Indicators Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Mesa Labs, Inc.
    • 11.2.2. LISTER BioMedical
    • 11.2.3. STERIS plc.
    • 11.2.4. Solventum
    • 11.2.5. Getinge
    • 11.2.6. 3M
    • 11.2.7. Terragene S.A.
    • 11.2.8. Propper Manufacturing Co., Inc.
    • 11.2.9. Tuttnauer
    • 11.2.10. Ecolab Inc.
    • 11.2.11. H.W.Andersen Products Ltd.
    • 11.2.12. MATACHANA GROUP
    • 11.2.13. Liofilchem S.r.l.
    • 11.2.14. Steelco S.p.A
    • 11.2.15. Zhejiang Tailin Bioengineering Co., Ltd.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us